Alkem Laboratories Ltd share price logo

Alkem Labs Share Price

NSE: ALKEM

BSE: 539523

Mid Cap

Healthcare Sector

5799.00

+6.00

(+0.10%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Alkem Labs Stock Performance

as on January 9, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹5,707
    ₹5,825
    downward going graph

    1.59%

    Downside

    0.45%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹4,491.65
    ₹5,868
    downward going graph

    22.54%

    Downside

    1.19%

    Upside

    downward going graph

Alkem Labs share price movements today

Previous Close
₹5,793.00
Open
₹5,775.50
Volume
1.34L
Upper Circuit
₹6,372.00
Lower Circuit
₹5,214.00
Day's Low - High
₹5,707 - ₹5,825
52 Week Low - High
₹4,491.65 - ₹5,868

Alkem Labs Historical Returns

1 Month Return
+ 3.58 %
3 Month Return
+ 6.32 %
1 Year Return
+ 7.87 %
3 Year Return
+ 88.31 %
5 Year Return
+ 87.41 %

Alkem Labs Fundamentals

as on January 9, 2026 at 4:01 pm IST

Market Cap

₹69,335.74 Cr

Return on Equity (ROE)

19.94

PE Ratio (TTM)

29.37

Return on capital employed (ROCE)

20.29

Industry PE ratio

42.25

Beta (LTM)

0.71

P/B Ratio

4.73

Dividend Yield

0.92

PEG Ratio

1.47

Quarterly Earnings Growth YOY

11.06

EPS (TTM)

185.36

Sector

Pharmaceuticals

Book Value

1002.5

Technical Analysis

Alkem Labs Stock Valuation

as on January 9, 2026 at 4:01 pm IST

Alkem Labs in the last 5 years

  • Overview

  • Trends

Lowest (20.07x)

March 24, 2021

Today (29.37x)

January 9, 2026

Industry (42.25x)

January 9, 2026

Highest (44.21x)

August 9, 2023

LowHigh

Today’s Price to Earnings Ratio: 29.37x

Alkem Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alkem Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
HOLD69,335.7417.48%0.592,21612,964
BUY23,762.093.88%0.544922,461
HOLD58,466.4741.87%0.713545,553
BUY10,219.7012.03%0.65143704
BUY7,243.458.46%0.5390687

Analyst Recommendation on Alkem Labs Stock

Based on 21 analysts

HOLD

47.62%

Buy

28.57%

Hold

23.81%

Sell

Based on 21 analysts, 47.62% of analysts recommend a 'HOLD' rating for Alkem Labs. Average target price of ₹5920.71

Source: S&P Global Market Intelligence

Alkem Labs Share Price Target

Get share price movements and forecasts by analysts on Alkem Labs.

What analysts predicted

2.1%UPSIDE

Target Price

₹5920.71

Current Price

₹5799

Analyzed by

21 Analysts

High

₹7056

Target

₹5920.71

Low

₹4410

Alkem Labs target price 5920.71, a slight upside of 2.1% compared to current price of ₹5799. According to 21 analysts rating.

Source: S&P Global Market Intelligence

Alkem Labs Stock’s Investor Sentiment and Interest

Search interest for Alkem Laboratories Ltd Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Alkem Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
2,902.6
2,967.72
3,440.17
3,323.87
2,935.82
3,031.82
3,414.67
3,374.28
3,143.75
3,371.14
4,000.99
Other Income
68.67
65.84
63.19
93.64
88.17
120.31
134.48
92.99
145.96
149.42
103.69
Total Income
2,971.27
3,033.56
3,503.36
3,417.51
3,023.99
3,152.13
3,549.15
3,467.27
3,289.71
3,520.56
4,104.68
Expenses
2,652.33
2,578.53
2,751.1
2,667.59
2,546.36
2,423.18
2,661.84
2,614.89
2,752.46
2,632.09
3,080.22
Operating Profit
250.27
389.19
689.07
656.28
389.46
608.64
752.83
759.39
391.29
739.05
920.77
Operating Profit Margin %
8.62%
13.11%
20.03%
19.74%
13.27%
20.08%
22.05%
22.51%
12.45%
21.92%
23.01%
Profit Before Interest, Tax and Depreciation
318.94
455.03
752.26
749.92
477.63
728.95
887.31
852.38
537.25
888.47
1,024.46
Interest
28.96
29.77
30.32
25.46
26.86
29.11
28.14
36.03
28.42
29.78
35.02
Depreciation
78.32
72.41
73.9
69.56
83.43
80.48
78.91
85.28
112.49
87.68
93.61
Profit Before Tax
211.66
352.85
648.04
654.9
367.34
619.36
780.26
731.07
396.34
771.01
895.83
Tax Paid
143.98
65.04
33.15
50.62
62.86
69.12
78.3
90.28
73.33
102.69
116.23
Profit After Tax
67.68
287.81
614.89
604.28
304.48
550.24
701.96
640.79
323.01
668.32
779.6
Total Net profit including share of profit / Loss from associate company
67.68
287.81
614.89
604.28
304.48
550.24
701.96
640.79
322.39
667.91
779.11
EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
Actual EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
Adjusted EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99
Diluted EPS
5.94
23.98
51.9
49.76
24.55
45.6
57.6
52.34
25.57
55.56
63.99

Alkem Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
5,852.5
6,401.17
7,357.19
8,344.36
8,865.01
10,634.19
11,599.26
12,667.58
12,964.52
Other Income
112.01
115.42
87.7
104.22
233.21
162.65
216.08
310.84
493.74
Total Income
5,964.51
6,516.59
7,444.89
8,448.58
9,098.22
10,796.84
11,815.34
12,978.42
13,458.26
Expenses
4,853.55
5,392.25
6,242.42
6,870.97
6,922.62
8,596.23
10,092.79
10,543.58
10,452.37
Operating Profit
998.95
1,008.92
1,114.77
1,473.39
1,942.39
2,037.96
1,506.47
2,124
2,512.15
Operating Profit Margin %
17.07%
15.76%
15.15%
17.66%
21.91%
19.16%
12.99%
16.77%
19.38%
Profit Before Interest, Tax and Depreciation
1,110.96
1,124.34
1,202.47
1,577.61
2,175.6
2,200.61
1,722.55
2,434.84
3,005.89
Interest
45.16
55.33
54.63
65.06
58.92
52.37
107.36
112.41
121.7
Depreciation
101.17
143.03
193.18
252.76
274.58
303.96
310.42
299.3
357.16
Profit Before Tax
964.63
925.98
954.66
1,259.79
1,842.1
1,844.28
1,304.77
2,023.13
2,527.03
Tax Paid
59.96
287.56
181.02
110.48
224.33
163.96
297.96
211.67
311.03
Profit After Tax
904.67
638.42
773.64
1,149.31
1,617.77
1,680.32
1,006.81
1,811.46
2,216
Total Net profit including share of profit / Loss from associate company
904.67
638.42
773.64
1,149.31
1,617.77
1,680.32
1,006.81
1,811.46
2,215.38
EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
Actual EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
Adjusted EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11
Diluted EPS
74.61
52.77
63.61
94.26
132.57
137.63
82.31
150.19
181.11

Alkem Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
725.84
471.13
266.04
779.65
585.08
1,264.9
1,111.02
1,682.5
1,948.07
1,912.84
Cash Flow from Investing Activities
204.74
-294.06
-350.52
-318.37
-737.34
-994.87
-1,432.63
119.94
-1,010.55
-1,288.25
Cash Flow from Financing Activities
-927.27
-137.88
84.56
-378.94
79.15
-271.75
379.57
-1,760.82
-1,145.01
-810.99
Net Cash Flow
3.31
39.58
0.08
82.34
-73.11
-1.72
57.96
41.62
-207.49
-186.4

Alkem Labs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
57.16%
57.16%
56.74%
56.74%
56.74%
56.38%
55.66%
55.66%
55.13%
53.04%
51.2%
DII
16.69%
15.43%
17.64%
14.94%
15.63%
18.57%
19.21%
18.01%
19.42%
21.8%
21.93%
FII
0%
0%
0%
0%
9.11%
8.69%
9.02%
10.15%
9.41%
9.11%
9.48%
Public
21.7%
20.86%
19.59%
18.86%
18.52%
16.36%
16.1%
16.18%
16.05%
16.05%
17.4%
Total Outstanding Shares
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
11,95,65,000
Total Shareholders
73,440
66,790
69,442
65,184
65,830
69,627
74,744
84,038
84,326
79,740
67,196

Mutual Funds that own Alkem Labs Stock

Check out the Mutual Funds with significant holdings in Alkem Labs.

Alkem Labs Corporate Actions

View detailed summary of the earnings and dividend history of Alkem Labs.

  • Alkem Laboratories Ltd Earnings Results

    Alkem Laboratories Ltd’s net profit jumped 11.1% since last year same period to ₹765.06Cr in the Q2 2025-2026. On a quarterly growth basis, Alkem Laboratories Ltd has generated 15.17% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Alkem Laboratories Ltd Dividends May,2025

    In the quarter ending March 2025, Alkem Laboratories Ltd has declared dividend of ₹8.00 per share on 29 May 2025 - translating a dividend yield of 0.86%.

    Read More about Dividends

Indices Featuring Alkem Labs Stock

Check stock indices that include Alkem Labs.

NIFTY PHARMA

₹22,761.00

-0.88 (-201.55%)

BSE Healthcare

₹43,677.65

-1.05 (-461.45%)

Nifty Midcap 150

₹21,985.90

-0.88 (-194.65%)

Nifty Healthcare

₹14,672.05

-0.92 (-136.5%)

S&P BSE 400 MidSmallCap

₹11,902.51

-1.17 (-140.79%)

Nifty MidSmallcap 400

₹19,846.50

-1.16 (-232.25%)

BSE 200

₹11,620.53

-0.79 (-92.31%)

BSE Mid-Cap

₹46,304.80

-0.9 (-419.79%)

BSE 500

₹36,807.62

-0.89 (-329.71%)

S&P BSE 250 LargeMidCap

₹11,013.77

-0.81 (-89.72%)

Nifty Midcap 100

₹59,748.15

-0.79 (-474.4%)

S&P BSE 150 MidCap

₹16,174.64

-0.93 (-151.66%)

Nifty 200

₹14,306.95

-0.79 (-114.1%)

Nifty LargeMidcap 250

₹16,607.05

-0.84 (-139.85%)

Nifty 500

₹23,467.35

-0.9 (-212.75%)

Insights on Alkem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ALKEM stock has moved up by 4.4%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 16.05% to 17.40% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 305.86 Cr → 765.06 Cr (in ₹), with an average increase of 33.6% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.28K Cr → 4.10K Cr (in ₹), with an average increase of 10.4% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 9.11% to 9.48% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 16.67% to 16.94% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 21.0% return, outperforming this stock by 13.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 153.2% return, outperforming this stock by 64.9%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 53.04% to 51.20% in Sep 2025 quarter

Alkem Labs Stock Futures & Options Contracts

View the latest movement in Alkem Labs Futures & Options, including strike prices, expiry dates, and percentage changes.

Alkem Labs Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ALKEM 27 Jan ₹6000 Call
January 27, 2026
₹6000
₹53.15
-5.95
-10.07%
ALKEM 27 Jan ₹5800 Call
January 27, 2026
₹5800
₹124.15
-4.05
-3.16%
ALKEM 27 Jan ₹6200 Call
January 27, 2026
₹6200
₹21
-4
-16%
ALKEM 27 Jan ₹5900 Call
January 27, 2026
₹5900
₹84.05
-3.3
-3.78%

Alkem Labs Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
ALKEM 27 Jan Fut
January 27, 2026
-
₹5796
-5.8
-0.1%
ALKEM 24 Feb Fut
February 24, 2026
-
₹5800.5
6.37
0.11%
ALKEM 30 Mar Fut
March 30, 2026
-
₹5782.5
-37.25
-0.64%

About Alkem Laboratories Ltd

Alkem Laboratories Ltd is a leading pharmaceutical company founded in 1973 by Mr. Samir C. Desai.

With its headquarters in Mumbai, India, Alkem Laboratories is engaged in the manufacture of a wide range of pharmaceutical products across multiple therapeutic categories, including cardiovascular, central nervous system, gastro-intestinal, anti-infective, diabetology, and nutrition. The company has a strong presence in the Indian market and exports its products to over 50 countries.

Revenue: ₹4,000.99Cr as on September 2025 (Q2 FY26)
Net Profit: ₹779.60Cr as on September 2025 (Q2 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Basudeo N Singh
OrganisationAlkem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOBasudeo N Singh
E-voting on sharesClick here to vote

FAQs

What is Alkem Labs share price today?

Alkem Labs share price today stands at ₹5799 as on at the close of the market. Alkem Labs share today touched a day high of ₹5825 and a low of ₹5707.

What is the 52 week high and 52 week low range for Alkem Labs share?

Alkem Labs touched a 52 week high of ₹5868 and a 52 week low of ₹4491.65. Alkem Labs share price today i.e. is closed at ₹5799, which is -1.18% down from its 52 week high and 29.11% up from its 52 week low.

What is Alkem Labs's market capitalisation today?

Alkem Labs market capitalisation is ₹69,335.74 Cr as on .

How to buy Alkem Labs shares?

To buy Alkem Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ALKEM or Alkem Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Alkem Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Alkem Labs trading volume today?

Alkem Labs trading volume is 1.34L as on . This means that 1.34L shares of Alkem Labs were bought and sold on the stock market during today's trading session.